Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 303601-303650 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT00000872
Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection
PHASE2
Completed
55 participants
1 condition
2 sponsors
12 locations
NCT00013169
Patient-Centered Alternative to Psychiatric Hospitalization for Veterans
NA
Completed
220 participants
2 conditions
1 sponsor
1 location
NCT00410748
Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)
PHASE3
Completed
388 participants
2 conditions
1 sponsor
0 locations
NCT00002299
The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NA
Completed
2 conditions
1 sponsor
6 locations
NCT00002122
A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients
PHASE3
Completed
720 participants
3 conditions
1 sponsor
12 locations
NCT00939458
Study of Lamotrigine 2 x 25 mg IR Tablets of Torrent Pharmaceuticals Pvt., Ltd., India and Lamictal ® (Lamotrigine) 2 x 25 mg Tablets of Glaxo-SmithKline, USA, in Healthy Human Adult Subjects, Under Fed Conditions
PHASE1
Completed
1 condition
1 sponsor
1 location
NCT00002232
A Study of GENEVAX-HIV, a Possible Vaccine
PHASE1
Completed
2 conditions
1 sponsor
1 location
NCT00215865
PEG-Interferon a-2b + Ribavirin for Treatment of Patients With Chronic Hepatitis C Who Have Previously Failed to Achieve a Sustained Virologic Response Following Interferon Alfa or Interferon a-2b + Ribavirin Therapy
PHASE3
Completed
600 participants
1 condition
2 sponsors
1 location
NCT00072774
Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
PHASE3
Completed
480 participants
1 condition
1 sponsor
0 locations
NCT00005116
Depression In Juvenile Diabetics
NA
Completed
2 conditions
1 sponsor
1 location
NCT00002409
The Effect of Teaching HIV-Infected Patients About HIV and Treatment
PHASE3
Completed
200 participants
1 condition
1 sponsor
25 locations
NCT00253123
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia
PHASE3
Completed
626 participants
3 conditions
1 sponsor
0 locations
NCT00000713
A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects
PHASE1
Completed
40 participants
1 condition
1 sponsor
1 location
NCT00011622
Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous Monitor
N/A
Completed
1 condition
1 sponsor
1 location
NCT00000358
Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7
PHASE1
Completed
2 conditions
2 sponsors
1 location
NCT00002140
A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients
PHASE3
Completed
2 conditions
1 sponsor
24 locations
NCT01089205
Bioequivalence Study of Metformin Hydrochloride Extended Release 750 mg Tablets Versus Glucophage XR® 750 mg Tablet in Healthy Volunteers Under Fed Conditions.
PHASE1
Completed
1 condition
1 sponsor
0 locations
NCT00002218
A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients
PHASE1
Completed
40 participants
1 condition
1 sponsor
6 locations
NCT00006196
The Relationship Between Vitamin D, Fingernail Thickness and Bone Density
PHASE1
Completed
1 condition
1 sponsor
1 location
NCT00001009
A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)
PHASE1
Completed
60 participants
1 condition
1 sponsor
8 locations
NCT00532506
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
PHASE2
Completed
1 condition
1 sponsor
10 locations
NCT00000643
Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
PHASE2
Completed
150 participants
2 conditions
1 sponsor
24 locations
NCT00002148
Parallel Group, Placebo-Controlled, Tolerability, Safety, and Efficacy Study of OPC-14117 in HIV Dementia
PHASE1
Completed
30 participants
2 conditions
1 sponsor
3 locations
NCT01086943
Clinical Safety Study on an Eyelid Warming Device to Evaluate the Eyelid and Cornea Temperature in Healthy Volunteers
PHASE1
Completed
25 participants
1 condition
1 sponsor
1 location
NCT00027209
Hormone Replacement in Menopausal Women With Epilepsy
PHASE2
Completed
125 participants
2 conditions
1 sponsor
1 location
NCT00483795
Pilot Evaluation of Two Multipurpose Solutions in Regards to Corneal Staining
PHASE4
Completed
1 condition
1 sponsor
1 location
NCT00013013
A Randomized Trial to Implement the AHCPR Smoking Cessation Guideline
PHASE4
Completed
4,000 participants
2 conditions
1 sponsor
1 location
NCT00044902
Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade)
PHASE2
Completed
1 condition
1 sponsor
0 locations
NCT00043732
Safety Study of SCIO-469 to Treat Patients With Active Rheumatoid Arthritis Receiving Methotrexate
PHASE2
Completed
120 participants
1 condition
1 sponsor
0 locations
NCT00002201
A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients
NA
Completed
1 condition
1 sponsor
1 location
NCT00044759
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
PHASE3
Completed
1 condition
1 sponsor
36 locations
NCT01108913
Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE2
Completed
60 participants
1 condition
1 sponsor
1 location
NCT00002359
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega
PHASE3
Completed
3,000 participants
1 condition
1 sponsor
54 locations
NCT01003743
Endolumenal Gastric Pouch and Gastrojejunal Anastomosis Reduction
NA
Completed
1 condition
1 sponsor
1 location
NCT00067795
Evaluating Immune Function Tests in People With HIV
N/A
Completed
54 participants
1 condition
1 sponsor
6 locations
NCT00034086
Study of Anti-HIV Therapy Intensification
NA
Completed
22 participants
1 condition
1 sponsor
3 locations
NCT00657579
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension
PHASE2
Completed
2 conditions
1 sponsor
1 location
NCT00478127
Hepatocyte Growth Factor and Cardiovascular Autonomic Function
N/A
Completed
1 condition
1 sponsor
0 locations
NCT01027247
OculusGen™ Collagen Matrix Implant for Phaco-Trabeculectomy in Primary Glaucoma: a Case-Control Study
PHASE3
Completed
1 condition
1 sponsor
0 locations
NCT00008528
T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
PHASE3
Completed
525 participants
1 condition
2 sponsors
37 locations
NCT01241994
Automatic Adaptive System Dialysis (AASD)
NA
Completed
1 condition
1 sponsor
1 location
NCT00002090
An Open, Multicenter, Randomized, Dose-Ranging Study of Azithromycin in the Treatment of Disseminated Mycobacterium Avium-Intracellulare Complex Infection (MAC) in Patients With Acquired Immune Deficiency Syndrome (AIDS)
NA
Completed
2 conditions
1 sponsor
6 locations
NCT00376857
Surgical Removal of Idiopathic Epiretinal Membrane With and Without the Assistance of Indocyanine Green.
NA
Completed
60 participants
1 condition
1 sponsor
1 location
NCT00002357
The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms
PHASE2
Completed
144 participants
1 condition
1 sponsor
6 locations
NCT00002203
A Study of Two Anti-HIV Drug Combinations
NA
Completed
1 condition
1 sponsor
7 locations
NCT00013741
The MI-HEART Project
NA
Completed
55 participants
2 conditions
1 sponsor
1 location
NCT00002138
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days.
PHASE1
Completed
2 conditions
1 sponsor
1 location
NCT00002399
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
PHASE2
Completed
500 participants
2 conditions
1 sponsor
53 locations
NCT00186563
A Human In-vivo Model for the Detection of Inflammatory and Nociceptive Biomarkers
NA
Completed
13 participants
1 condition
1 sponsor
1 location
NCT00863005
Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study
PHASE1/PHASE2
Completed
1 condition
1 sponsor
1 location
Previous
1
More pages
6070
6071
6072
6073
6074
6075
6076
More pages
6093
Next